Abstract
Based on the previous discovery of the inhibitory effect of the 5-substituted 2-amino-4,6-dichloropyrimidines on nitric oxide (NO) production in vitro, a series of novel pyrimidine derivatives, namely 4,6-dichloro-2-[(N,N-dimethylamino)methyleneamino]pyrimidines, 2,4-diamino-6-chloropyrimidines, and 2,4-diamino-6-(2-hydroxyethoxy)pyrimidines, were prepared bearing various substituents at the C-5 position on the pyrimidine, such as hydrogen, methyl, ethyl, propyl, isopropyl, propargyl, allyl, butyl, sec-butyl, phenyl, benzyl, and fluorine. The intrinsic biological potential of the prepared compounds was characterized by effects on the in vitro production of immune-activated NO in mouse peritoneal cells. All 5-substituted 4,6-dichloro-2-[(N,N-dimethylamino)methyleneamino]pyrimidines strongly inhibited NO production. The IC50s were <5 µM in most cases. The highest inhibitory activity was observed for the 5-sec-butyl analog (IC50 = 2.57 µM), the lowest one for 5-unsubtituted compound (IC50 = 11.49 µM). With the exception of the 5-fluoro-4,6-dichloro-2-[(N,N-dimethylamino)methyleneamino] derivative, all other compounds were devoid of cytotoxic effects. The hitherto obtained data suggest that the NO-inhibitory activity depends on the presence of the 2-amino-4,6-dichloropyrimidine scaffold.
Similar content being viewed by others
References
Aktan F (2004) iNOS-mediated nitric oxide production and its regulation. Life Sci 75:639–653
Dračínský M, Holý A, Jansa P, Kovačková S, Buděšínský M (2009) Isotopic exchange of hydrogen at C-5 in pyrimidine derivatives: tautomers with an sp3-hybridised C-5 carbon atom. Eur J Org Chem 24:4117–4122
Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG (1997) 1400 W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272:4959–4963
Guler R, Olleros ML, Vesin D, Parapanov R, Vesin C, Kantengwa S, Rubbia-Brandt L, Mensi N, Angelillo-Scherrer A, Martinez-Soria E, Tacchini-Cottier F, Garcia I (2004) Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J Hepatol 41:773–781
Haskó G, Kuhel DG, Chen JF, Schwarzchild MA, Deitch EA, Mabley A, Szabó C (2000) Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 14:2065–2074
Hesslinger C, Strub A, Boer R, Ulrich WR, Lehner MD, Braun C (2009) Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochem Soc Trans 37:886–891
Hobbs AJ, Higgs A, Moncada S (1999) Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39:191–220
Hocková D, Holý A, Masojidková M, Andrei G, Snoeck R, De Clercq E, Balzarini J (2003) 5-Substituted-2,4-diamino-6-2-(phosphonomethoxy)ethoxy]pyrimidines—acyclic nucleoside phosphonate analogues with antiviral activity. J Med Chem 46:5064–5073
Holý A, Votruba I, Masojídková M, Andrei G, Snoeck R, Naesens L, De Clercq E, Balzarini J (2002) 6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity. J Med Chem 45:1918–1929
Jadeski LC, Hum KO, Chakraborty C, Lala PK (2000) Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 85:30–39
Jain KS, Chitre TS, Miniyar PB, Kathiravan MK, Bendre VS, Veer VS, Shahane SR, Shishoo CJ (2006) Biological and medicinal significance of pyrimidines. Curr Sci India 90:793–803
Jansa P, Holý A, Dračínský M, Kolman V, Janeba Z, Kostecká P, Kmoníčková E, Zídek Z (2014) 5-Substituted 2-amino-4,6-dihydroxypyrimidines and 2-amino-4,6-dichloropyrimidines: synthesis and inhibitory effects on immune-activated nitric oxide production. Med Chem Res. doi:10.1007/s00044-014-1018-9
Lagoja IM (2005) Pyrimidine as constituent of natural biologically active compounds. Chem Biodivers 2:1–50
Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS (1988) Macrophage oxidation of l-arginine to nitrite and nitrate. Biochemistry 27:8706–8711
Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012
Mordan LJ, Brunett TS, Zhang LX, Tom J, Cooney RV (1993) Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcinogenesis 14:1555–1559
Ouyang J, Xu D, Zhang X, Qi S, Ma A, Jiang W, Chida N, Sudo Y, Tamura K, Daloze P, Chen H (2005) Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections. Transplantation 79:1386–1392
Rao KMK (2000) Molecular mechanisms regulating iNOS expression in various cell types. J Toxicol Environ Health B 3:27–58
Reichardt C (1999) Vilsmeier–Haack–Arnold formylations of aliphatic substrates with N-chloromethylene-N,N-dimethylammonium salts. J Prakt Chem 341:609–661
Sakai N, Kaufman S, Milstein S (1993) Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line (RAW 264). Mol Pharmacol 43:6–10
Schoedon G, Schneemann M, Hofer S, Guerrero L, Blau N, Schaffner A (1993) Regulation of the l-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages. Eur J Biochem 213:833–839
Selvam TP, James CR, Dniandev PV, Valzita SK (2012) A mini review of pyrimidine and fused pyrimidine marketed drugs. Res Pharm 2:1–9
Sung YJ, Hotchkiss JH, Dietert RR (1994) 2,4-Diamino-6-hydroxypyrimidine, an inhibitor of GTP cyclohydrolase I, suppresses nitric oxide production by chicken macrophages. Int J Immunopharmacol 16:101–108
Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H (1990) Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J Exp Med 172:1599–1607
Ying C, Holý A, Hocková D, Havlas Z, De Clercq E, Neyts J (2005) Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities. Antimicrobial Agents Chemother 49:1177–1180
Zídek Z (1999) Adenosine-cyclic AMP pathways and cytokine expression. Eur Cytokine Netw 10:319–328
Acknowledgments
The research was supported by Grant CZ: GA ČR: GA303/12/0172 from the Czech Science Foundation and by the Ministry of Interior of the Czech Republic (VG20102015046).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Antonín Holý—deceased.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jansa, P., Holý, A., Dračínský, M. et al. Synthesis and structure–activity relationship studies of polysubstituted pyrimidines as inhibitors of immune-activated nitric oxide production. Med Chem Res 24, 2154–2166 (2015). https://doi.org/10.1007/s00044-014-1285-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-014-1285-5